Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test
Considerations for Assessing Risk of Provider Exposure to SARS-CoV-2 after a Negative Test
复制标题
阴性检测后评估提供者接触 SARS-CoV-2 风险的注意事项
DOI:
10.1097/aln.0000000000003392
复制
发表时间:
2020
期刊:
影响因子:
8.8
通讯作者:
Van Cleve, Wil
中科院分区:
文献类型:
--
作者:
Long, Dustin R.;Sunshine, Jacob E.;Van Cleve, Wil
Coronavirus disease 2019 (COVID-19) is caused by infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The transmission of coronaviruses occurs via direct contact, droplets, and aerosols. Healthcare professionals involved in airway management of patients infected with SARS-CoV-2 are at high risk of exposure and subsequent infection, as has been observed in previous coronavirus epidemics. 1 This risk is most pronounced in aerosol-generating procedures such as intubation. On March 22, 2020, the American Society of Anesthesiologists (Schaumburg, Illinois), in partnership with other professional organizations, offered guidance for the use of personal protective equipment that have been interpreted by some providers as recommending the use of airborne precautions for all aerosol-generating procedures during the pandemic. 2Healthcare systems operating under pandemic conditions may need to balance the protection of staff with the allocation of scarce resources, including personal protective equipment. One strategy to address this problem relies on preprocedural testing of asymptomatic individuals. Recent publication of data suggesting imperfect clinical sensitivity of reverse transcription polymerase chain reaction assays for SARS-CoV-23 could lead healthcare providers to intuitively question the wisdom of a strategy that relies on a negative SARS-CoV-2 test, particularly when planning high-risk procedures such as endotracheal intubation. Knowledge of test characteristics, however, is insufficient to guide decision making: the prevalence of the disease in the population for which the test is performed has a critical bearing on the information provided by the test. Prevalence estimates are complicated by the fact that they will differ (sometimes substantially) between different locations, may be unavailable or poorly measured, and will be inherently dynamic during a pandemic. These uncertainties may substantially affect the safety of both patients and providers and may impact the utilization of scarce resources such as personal protective equipment.
DOI:
--
发表时间:
1962
期刊:
影响因子:
--
作者:
C. E. Clark
通讯作者:
C. E. Clark
DOI:
--
发表时间:
2014
期刊:
影响因子:
--
作者:
R. Pouillot
通讯作者:
R. Pouillot